Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

NCT01985841 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Breast Cancer

Interventions

DRUG: Bevacizumb
DRUG: 5-Fluorouracil
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel

Sponsor

Hellenic Oncology Research Group